NCT03907475: Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- State
- Under way
- Phase
- Phase 2
- People
- 115 planned
- Started
- 16 Jul 2019
- Primary completion
- 1 Jun 2027
- Arms
- Arm VI (paclitaxel, durvalumab)
- Results
- None posted
- 9 Apr 2019: Trial registered
- 16 Jul 2019: Trial started